Yanzhi Bu

LINC00857 contributes to hepatocellular carcinoma malignancy via enhancing epithelial‐mesenchymal transition

Weixing Wang, Chaofeng Xia, Xiaoyu Zhang, 2018, Journal of cellular biochemistry.

miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1.

Jie Tang, Xiaoyu Zhang, Yanzhi Bu, 2018, International journal of oncology.

RNA‐binding protein RBM38 inhibits colorectal cancer progression by partly and competitively binding to PTEN 3′UTR with miR‐92a‐3p

Jun Ma, D. Huang, Yanzhi Bu, 2021, Environmental toxicology.

LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway

Xiaoyu Zhang, Yanzhi Bu, Yong-Fa Zheng, 2018, Journal of cellular biochemistry.

LINC01433 promotes hepatocellular carcinoma progression via modulating the miR‐1301/STAT3 axis

Xiaoyu Zhang, Yanzhi Bu, Juan Liu, 2018, Journal of cellular physiology.

Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathway

Min Shi, Min Shi, Yanzhi Bu, 2018, Journal of cellular biochemistry.

Long noncoding RNA CA3-AS1 suppresses gastric cancer migration and invasion by sponging miR-93-5p and targeting BTG3

Yu Shen, Xiaoyu Zhang, Yanzhi Bu, 2020, Gene Therapy.

Down-regulated C4orf19 confers poor prognosis in colon adenocarcinoma identified by gene co-expression network

Yanzhi Bu, R. Yu, Suqin Zhou, 2022, Journal of Cancer.